Cancer Institute A national cancer institute
designated cancer center

March 2011 Cancer Center Bulletin

Director's Update

We are near the end of Year 1 of our five-year renewal of NCI funding.  Thanks to everyone’s efforts, we stand out as a highly innovative Cancer Center, but there remains much to do to realize our full potential.  In our new Lokey location, we have a terrific administrative staff whose function is to facilitate new research initiatives and to help integrate research activities across disciplines. With SHC, we are engaging in a strategic planning process for clinical services that, we anticipate, will complement our basic, population and clinical research programs. We hope that many of you will attend the all-members retreat on April 11 bringing postBSM_Signatureers and news of your activities to share with us.

 

Cancer Prevention Institute of California Newsletter

http://www.cpic.org/site/c.skI0L6MKJpE/b.6573807/k.69E0/February_eNewsletter_2011.htm

Key Dates

March 25 & 26, 2011

The 12th Multidisciplinary Management of Cancers: A Case-based Approach
Li Ka Shing Center for Learning & Knowledge, 2nd Floor Conference Center
This is a unique CME meeting with its emphasis on tumor board cases.
To see the brochure and registration information, visit::
http://cancer.stanford.edu/documents/2010CME-CancerBrFinalp4.pdf

April 11, 2011

Stanford Cancer Center Members’ Retreat
Quadrus Conference Center
Details forthcoming       

May 28, 2011

Canary Century Bike Event, benefiting the Stanford Cancer Center.  For registration and more information visit http://www.canarycentury.com/

CANCER CENTER GRANT OPPORTUNITIES (DCRAs and V Foundation)

The Cancer Center awards Developmental Cancer Research Awards (DCRAs).  The DCRA program provides multiple $50,000 seed grants for new ideas in translational and population science research. It provides one $100,000 grant for ideas that foster interactive research projects.  There will be a new announcement for DCRAs later this month.  The V Foundation Translational Cancer Research grant, which last year offered one $600,000 grant (over 3 years), will also be announced this month.

Grant announcements are distributed to Cancer Center members via email. For additional information, please contact Denise Baughman at deniseb@stanford.edu

CANCER CENTER NEWS

The Cancer Biology Interdisciplinary PhD Program now administratively reports to the Cancer Center.  Dr. Amato Giaccia, the Cancer Center’s Associate Director for Education, oversees the program.   Grace Kolaer is the administrative director.  More information can be found at http://cancerbio.stanford.edu/Welcome.html.

The Cancer Center non-competing renewal is due to the NCI on April 1.  Program leaders and core leaders are urged to send their reports to Dr. Babette Heyer (bheyer@stanford.edu).

Under the leadership of Dr. Jonathan Berek, the Cancer Center submitted a Specialized Projects of Research Excellence (SPORE) grant application to the NCI.  The proposal focuses on ovarian cancer and consists of five interacting projects and four cores.

KUDOS

http://med.stanford.edu/ism/people/images/elias-joshua.jpgJoshua Elias, PhD, assistant professor of chemical and systems biology, is one of five recipients of the 2011 Damon Runyon-Rachleff Innovation Award. The Damon Runyon Cancer Research Foundation awards the $450,000 grant to scientists carrying out especially innovative work early in their careers. The grant will allow him to advance his research into how cancer cells survive despite a tendency to produce more damaged proteins than most ordinary cells. Elias suspects that cancer cells have ways of deactivating the abnormal proteins and that they might also use cell division as a way to escape them.

David Spiegel, Professor in Psychiatry and Behavioral Sciences has been given the 2011 Arthur M. Sutherland Award from the International Psycho-Oncology Society. From their website: "It honors an IPOS or psycho-oncology community member with a lifetime achievement in the field of psycho-oncology. This is a late career award and recognizes sustained and distinguished output in psycho-oncology over their whole career. This is the Society’s most important award and reflects the international standing of the recipient. The recipient will have achieved international recognition for their work and be considered to have contributed important innovations to the field of psycho-oncology. Quantity of output is less important than evidence of international standing and innovation across an individual’s whole career."

Michelle Monje, MD, PhD, an instructor in neurology and neurological sciences at Stanford, is the primary author of a study dealing with Diffuse Intrinsic Pontine Glioma, published online Feb. 28 in Proceedings of the National Academy of Sciences.  The article describes Stanford’s groundbreaking work in culturing human cells from this cancer and creating an animal model.  Full article at http://www.pnas.org/content/early/2011/03/01/1101657108

MARCH SEMINARS

Tumor Biology Seminar, Mitotic Checkpoints, Aneuploidy and Cancer
Mar 15, 2011 (Tue) | noon-1:30 pm, Beckman Center - Munzer Auditorium
Department:
Pathology
Contact: Elaine Ruiz | 723-7042 | eruiz@stanford.edu
Presenter: Robert Benezra, PhD, Memorial Sloan-Kettering Cancer Center

CCNE Nao-Bio Seminar Series, The See and Treat Strategy: Targeting Nanoparticles for Cancer Theranostics
Mar 15, 2011 (Tue) | 4:30-5:30 pm
Clark Center Auditorium
Department:
Molecular Imaging Program at Stanford
Contact: Billie Robles | 6-0196 | brobles@stanford.edu
Presenter: Chun Li, PhD
Professor, Department of Experimental Diagnostic Imaging, MD Anderson Cancer Center, University of Texas

12th Multidisciplinary Management of Cancer:  A Case-based Approach
Mar 25, 2011 (Fri) - Mar 26, 2011 (Sat)
LKSC,
brochure and registration information at: http://cancer.stanford.edu/documents/2010CME-CancerBrFinalp4.pdf

Nuclear Medicine Grand Rounds
Title TBD
March 29, 2011 (Tue) | 7:30-8:30 am
Department:
Molecular Imaging Program at Stanford
Contact: Donna Niernberger | 650-736-0449 | donnan52@stanford.edu
Presenter: Beverly S. Mitchell, MD
Director, Stanford Cancer Center

Cancer Biology Seminar
Applying Genetically Engineered Mouse Models of Lung and Pancreatic Cancer to Facilitate Drug Development
Mar 29, 2011 (Tue) | noon-1:30 pm
Beckman Center - Munzer Auditorium
Department:
Cancer Biology
Contact: Grace Kolar| (650) 723-6198 | gracebk@stanford.edu
Presenter: Lisa Johnson, PhD, Senior Scientist

Stanford Medicine Resources:

Footer Links: